According to RBC, Pharmeco Group appears in top-500 of the biggest businesses in Russia
Pharmeco Group of companies is a Russian vertically integrated holding company operating in all major segments of the pharmaceutical market, i.e. R&D, production and distribution of medicinal drugs, medical equipment and other products of medical use.
The year 2021 saw the 20th anniversary since the incorporation of Pharmeco. The Group now also includes ZiO-Zdorovye (Podolsk) and Dobrolek (Moscow) pharmaceutical factories. The enterprises comply with all present-day standards that apply to production and quality control (GMP). The Group is also engaged in designing its own proprietary medicinal drugs.
The distribution part of the group is represented by IRWIN, a top-3 player in the public procurement segment (as reported by IQVIA analytics agency on Q1 2023 results). The company ensures availability of modern and efficient medicinal drugs, medical equipment and other products of medical use across the entire Russia by its cutting-edge system of logistics and distribution. IRWIN’s warehouse of 10,500 m2 floor space is located in Podolsk. The company’s comprehensive system of warehousing and logistics is fully compliant with GSP and GDP international standards.
According to RBC, Pharmeco Group appears in top-500 of the biggest businesses in Russia
Pharmeco group is an initiator and a partner to a number of charitable and socially meaningful projects intended on supporting the physical and mental wellbeing of the nation. As a socially responsible business, Pharmeco works with organizations at federal and local levels, it develops programs and initiatives that help children left without parental care, promote sports and healthy lifestyle, support national cultural and spiritual values.
You cannot imagine growth without change and those who’re unable to change their mindset cannot change anything.
